drugset / Trial / NCT04831255

ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis

NCT04831255

Phase 1 Terminated 39 enrolled University of Virginia
NaSingle-groupOpen-labelTreatment

Summary

Adhesive capsulitis is a fairly common orthopedic condition that causes pain and loss of range of motion. There are a variety of ways to treat adhesive capsulitis, one of them being an intra-articular steroid injection. This is done to help decrease the inflammatory response caused by adhesive capsulitis. In this study, all participants will receive an intra-articular glenohumeral injection of ZILRETTA and will be followed up with at four time points over 1 year to observe pain, function and range of motion following the injection.

Timeline

Start
2019-06-21
Primary completion
2023-08-31
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified 32 mg Other

Indications